Cytosorbents Corp Company Profile (OTCMKTS:CTSO)

About Cytosorbents Corp

Cytosorbents Corp logoCytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery and autoimmune disease flares and cancer cachexia. It also has other products under development based upon its blood purification technology, including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: CTSO
  • CUSIP:
Key Metrics:
  • Previous Close: $4.95
  • 50 Day Moving Average: $4.83
  • 200 Day Moving Average: $4.52
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.50
  • P/E Growth: 0.00
  • Market Cap: $125.91M
  • Outstanding Shares: 25,437,000
Additional Links:
Companies Related to Cytosorbents Corp:

Analyst Ratings

Consensus Ratings for Cytosorbents Corp (OTCMKTS:CTSO) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.00

Analysts' Ratings History for Cytosorbents Corp (OTCMKTS:CTSO)
DateFirmActionRatingPrice TargetDetails
8/8/2016Maxim GroupReiterated RatingBuy$8.00View Rating Details
5/10/2016HC WainwrightReiterated RatingBuyView Rating Details
5/10/2016Brean CapitalReiterated RatingBuyView Rating Details
10/29/2015WBB SecuritiesUpgradeSpeculative Buy -> Buy$13.00View Rating Details
5/12/2015MLV & Co.Lower Price TargetBuy$28.00 -> $21.00View Rating Details
(Data available from 8/29/2014 forward)


Earnings History for Cytosorbents Corp (OTCMKTS:CTSO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016Q216($0.09)($0.12)$2.18 million$1.90 millionViewN/AView Earnings Details
5/9/2016Q116($0.10)($0.08)$1.73 million$1.80 millionViewN/AView Earnings Details
3/9/2016Q415($0.08)($0.08)$1.58 millionViewN/AView Earnings Details
11/13/2015Q315($0.10)($0.11)$1.26 million$1.30 millionViewListenView Earnings Details
8/13/2015Q215($0.11)$0.05$1.69 millionViewListenView Earnings Details
5/11/2015Q115($0.13)($0.11)$724.00 millionViewListenView Earnings Details
11/13/2014($0.01)($0.01)ViewN/AView Earnings Details
8/12/2014($0.01)($0.01)ViewN/AView Earnings Details
3/31/2014($0.01)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cytosorbents Corp (OTCMKTS:CTSO)
Current Year EPS Consensus Estimate: $-0.39 EPS
Next Year EPS Consensus Estimate: $-0.30 EPS


Dividend History for Cytosorbents Corp (OTCMKTS:CTSO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Cytosorbents Corp (OTCMKTS:CTSO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/24/2016Phillip P ChanInsiderBuy5,000$4.89$24,450.00View SEC Filing  
6/7/2016Michael G BatorDirectorBuy3,000$4.88$14,640.00View SEC Filing  
10/29/2015Vincent CapponiCOOSell4,000$7.50$30,000.00View SEC Filing  
10/15/2015Al KrausDirectorSell6,774$6.22$42,134.28View SEC Filing  
10/8/2015Al KrausDirectorSell10,000$6.39$63,900.00View SEC Filing  
10/1/2015Al KrausDirectorSell10,000$6.26$62,600.00View SEC Filing  
9/24/2015Al KrausDirectorSell10,000$6.44$64,400.00View SEC Filing  
9/17/2015Al KrausDirectorSell10,000$6.64$66,400.00View SEC Filing  
9/10/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  
9/3/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  
8/27/2015Al KrausDirectorSell10,000$6.39$63,900.00View SEC Filing  
8/20/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  
8/13/2015Al KrausDirectorSell10,000$6.26$62,600.00View SEC Filing  
7/23/2015Al KrausDirectorSell10,000$6.28$62,800.00View SEC Filing  
7/16/2015Al KrausDirectorSell10,000$6.33$63,300.00View SEC Filing  
7/9/2015Al KrausDirectorSell10,000$5.98$59,800.00View SEC Filing  
7/2/2015Al KrausDirectorSell10,000$6.29$62,900.00View SEC Filing  
6/25/2015Al KrausDirectorSell13,205$7.33$96,792.65View SEC Filing  
6/18/2015Al KrausDirectorSell10,000$5.78$57,800.00View SEC Filing  
6/11/2015Al KrausDirectorSell10,000$6.29$62,900.00View SEC Filing  
6/4/2015Al KrausDirectorSell10,000$6.30$63,000.00View SEC Filing  
5/28/2015Al KrausDirectorSell10,000$6.32$63,200.00View SEC Filing  
11/17/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
11/10/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
11/3/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
10/27/2014Al KrausDirectorSell100,000$0.24$24,000.00View SEC Filing  
10/10/2014James T GuntonDirectorSell1,240,762$0.24$297,782.88View SEC Filing  
10/6/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
9/29/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
9/25/2014Al KrausDirectorSell41,500$0.23$9,545.00View SEC Filing  
9/22/2014Al KrausDirectorSell8,500$0.23$1,955.00View SEC Filing  
9/15/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
9/12/2014James T GuntonDirectorSell30,450$0.24$7,308.00View SEC Filing  
9/8/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
9/5/2014James T GuntonDirectorSell100,000$0.24$24,000.00View SEC Filing  
9/2/2014Al KrausDirectorSell50,000$0.25$12,500.00View SEC Filing  
9/2/2014Kathleen P BlochCFOBuy65,000$0.23$14,950.00View SEC Filing  
8/28/2014James T GuntonDirectorSell214,387$0.24$51,452.88View SEC Filing  
8/27/2014James T GuntonDirectorSell1,360,000$0.24$326,400.00View SEC Filing  
8/25/2014Al KrausDirectorSell100,000$0.25$25,000.00View SEC Filing  
8/18/2014Al KrausDirectorSell100,000$0.27$27,000.00View SEC Filing  
8/11/2014Al KrausDirectorSell100,000$0.28$28,000.00View SEC Filing  
8/4/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
7/21/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
7/10/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
7/7/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
6/23/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
6/18/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
5/20/2014Kathleen P BlochCFOBuy110,000$0.24$26,400.00View SEC Filing  
9/4/2012Phillip P ChanCEOBuy190,000$0.13$24,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cytosorbents Corp (OTCMKTS:CTSO)
News IconCrowd Views on Cytosorbents Corporation (NASDAQ:CTSO) - Post News (OTCMKTS:CTSO) - August 24 at 4:28 PM
News IconCrowd is Weighing in on Cytosorbents Corporation (NASDAQ:CTSO) - Post News (OTCMKTS:CTSO) - August 18 at 9:26 AM logoExclusive: Cytosorbents CEO On How Its Blood Purification Technology Can Change Healthcare - Benzinga (OTCMKTS:CTSO) - August 15 at 11:45 AM logoCTSO: Reorders Fuel Record Product Sales. New Territories Coming Online Will Complement This (OTCMKTS:CTSO) - August 15 at 11:45 AM logo8.9.16 CytoSorbents Achieves 4th Consecutive Quarter of Record CytoSorb Sales (OTCMKTS:CTSO) - August 11 at 9:53 AM logo8.8.16 CytoSorbents Awarded $650K in SBIR contracts to for Potassium Binder Development (OTCMKTS:CTSO) - August 11 at 9:53 AM logoCytoSorbents reports 2Q loss (OTCMKTS:CTSO) - August 10 at 8:13 AM logoCytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales (OTCMKTS:CTSO) - August 9 at 5:33 PM logoQ2 2016 Cytosorbents Corp Earnings Release - After Market Close (OTCMKTS:CTSO) - August 9 at 9:56 AM logoCytoSorbents Awarded $650000 in SBIR Grant Contracts to Continue Development of Novel Hemocompatible ... - PR Newswire (press release) (OTCMKTS:CTSO) - August 8 at 4:33 PM logoCytoSorbents Awarded $650,000 in SBIR Grant Contracts to Continue Development of Novel Hemocompatible Potassium Binding Polymers (OTCMKTS:CTSO) - August 8 at 9:17 AM logo8:32 am CytoSorbents receives $650k grant in funding through two separate Small Business Innovation Research grant contracts by the U.S. Army Medical Research and Materiel Command (OTCMKTS:CTSO) - August 8 at 9:17 AM logo8.2.16 CytoSorbents to Report Q2 2016 Operating and Financial Results (OTCMKTS:CTSO) - August 5 at 9:46 PM logoCan Cytosorbents Corporation (NASDAQ:CTSO) Meet Analysts Expectations? - Stocks Daily (OTCMKTS:CTSO) - August 5 at 10:29 AM logoCytoSorbents to Report Q2 2016 Operating and Financial Results - PR Newswire (press release) (OTCMKTS:CTSO) - August 3 at 9:58 AM logoCytoSorbents to Report Q2 2016 Operating and Financial Results (OTCMKTS:CTSO) - August 2 at 9:18 AM logoETF’s with exposure to CytoSorbents Corp. : July 29, 2016 (OTCMKTS:CTSO) - July 29 at 12:41 PM
News IconEquity Roundup: Stock Performance Focus on Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph (OTCMKTS:CTSO) - July 21 at 4:38 PM
News IconIt Seems Cytosorbents Corp Will Go Up. Have Another Big Increase - Consumer Eagle (OTCMKTS:CTSO) - July 20 at 11:48 PM
News IconCytosorbents Corporation (NASDAQ:CTSO) Shorts Decreased by 2.44% After Short Covering - Press Telegraph (OTCMKTS:CTSO) - July 20 at 11:48 PM logoCytosorbents Corporation Stock Momentum at Critical Inflection Point - CML News (OTCMKTS:CTSO) - July 18 at 4:02 PM
News IconCytosorbents Corp (NASDAQ:CTSO) Sentiment Drops in 2016 Q1 - Press Telegraph (OTCMKTS:CTSO) - July 18 at 4:02 PM
News IconCytosorbents Corporation (NASDAQ:CTSO) Earnings Concentration and Analyst Target Watch - Engelwood Daily (OTCMKTS:CTSO) - July 15 at 9:13 AM
News IconAnalyst Target and Average Rating Watch: Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph (OTCMKTS:CTSO) - July 15 at 9:13 AM logo7.13.16 Medial and Meditrade Bring CytoSorb to Hungary, Czech Republic, Slovakia and Poland (OTCMKTS:CTSO) - July 14 at 5:08 PM logo7.6.16 CytoSorbents To Presents at Cantor Fitzgerald Healthcare Conference (OTCMKTS:CTSO) - July 14 at 5:08 PM
News IconTrading Performance and Target Watch for Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph (OTCMKTS:CTSO) - July 14 at 4:43 PM
News IconCytosorbents Corporation (NASDAQ:CTSO) Shorted Shares Decreased By 0.72% - Consumer Eagle (OTCMKTS:CTSO) - July 14 at 7:37 AM
News IconCytosorbents Corporation (NASDAQ:CTSO) Wall Street Analyst Recommendation Outlook - Telanagana Press (OTCMKTS:CTSO) - July 13 at 4:35 PM logoCytoSorbents Teams with Medial and Meditrade to Bring CytoSorb® to Hungary, Czech Republic, Slovakia, and Poland (OTCMKTS:CTSO) - July 13 at 8:00 AM logoOption Market: Cytosorbents Corporation Risk Hits An Elevated Level - CML News (OTCMKTS:CTSO) - July 12 at 4:37 PM
News IconStock Rating Watch and Earnings Insight for Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph (OTCMKTS:CTSO) - July 11 at 9:17 AM
News IconCytosorbents Corporation (NASDAQ:CTSO) Sellers Covered 0.72% of Their Shorts - Press Telegraph (OTCMKTS:CTSO) - July 10 at 9:04 AM logo7.1.16 CytoSorbents Closes $10M Debt Financing with Bridge Bank (OTCMKTS:CTSO) - July 8 at 11:51 PM logo6.22.16 CytoSorbents Awarded $150K Universal Plasma Phase I STTR (OTCMKTS:CTSO) - July 8 at 11:51 PM logo6.13.16 CytoSorbents and Palex Bring CytoSorb to Spain and Portugal (OTCMKTS:CTSO) - July 8 at 11:51 PM
News IconCan Cytosorbents Corporation (NASDAQ:CTSO) Improve on the Earnings Front? - Engelwood Daily (OTCMKTS:CTSO) - July 8 at 4:30 PM
News IconCompany Stock Focus for Cytosorbents Corporation (NASDAQ:CTSO): Which Way Will Shares Head? - Press Telegraph (OTCMKTS:CTSO) - July 8 at 4:30 PM logoCytoSorbents' blood filter is saving lives and money (OTCMKTS:CTSO) - July 7 at 10:08 AM
News IconCytosorbents Corporation (NASDAQ:CTSO) Stock Update: Check on Ratings and Target Price - Telanagana Press (OTCMKTS:CTSO) - July 6 at 9:12 AM
News IconShare Performance Recap for: Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph (OTCMKTS:CTSO) - July 6 at 9:12 AM logoCytoSorbents to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference (OTCMKTS:CTSO) - July 6 at 7:00 AM logoCYTOSORBENTS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements (OTCMKTS:CTSO) - July 1 at 7:21 AM logoCytoSorbents Closes $10 Million Debt Financing with Bridge Bank (OTCMKTS:CTSO) - July 1 at 7:00 AM
News IconEquity Research and Technical Review on Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph (OTCMKTS:CTSO) - June 30 at 4:43 PM
News IconCytosorbents Corporation (NASDAQ:CTSO) Sellers Covered 0.72% of Their Shorts - Engelwood Daily (OTCMKTS:CTSO) - June 30 at 10:46 AM
News IconCytosorbents Corporation (NASDAQ:CTSO) Company Rating and Target Watch - Telanagana Press (OTCMKTS:CTSO) - June 29 at 9:29 PM
News IconShare Update and Earnings Review for Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph (OTCMKTS:CTSO) - June 27 at 4:29 PM
News IconCytosorbents Corporation (NASDAQ:CTSO) Earnings Glance and Target Price Review - Engelwood Daily (OTCMKTS:CTSO) - June 25 at 8:20 AM
News IconCovering the Bases on Cytosorbents Corporation (NASDAQ:CTSO): Where is the Stock Going? - Press Telegraph (OTCMKTS:CTSO) - June 25 at 8:20 AM


Cytosorbents Corp (OTCMKTS:CTSO) Chart for Monday, August, 29, 2016

Last Updated on 8/29/2016 by Staff